Edition:
United Kingdom

People: Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

22.30USD
13 Sep 2019
Change (% chg)

$-0.32 (-1.41%)
Prev Close
$22.62
Open
$22.52
Day's High
$22.83
Day's Low
$21.67
Volume
913,050
Avg. Vol
534,041
52-wk High
$45.12
52-wk Low
$19.37

Dixon, Wendy 

Dr. Wendy L. Dixon Ph.D. is Independent Director of the Company. Dr. Dixon has extensive experience in the pharmaceutical and biotechnology industries, combining a technical background with experience in drug development, regulatory affairs and marketing. She directed the launches and growth of more than 20 pharmaceutical products. From 2001 to 2009 she was Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb where she served on the Executive Committee. From 1996 to 2001 she was Senior Vice President, Marketing at Merck, and prior to that, she held executive management positions at West Pharmaceuticals, Osteotech and Centocor and various positions at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. Dr. Dixon is on the board of directors of Incyte Corporation, bluebird bio, Eleven Biotherapeutics and Voyager Therapeutics, all publicly traded biotechnology or pharmaceutical companies, and was formerly on the board of Ardea Biosciences, Dentsply International, Edimer Pharmaceuticals, Furiex Pharmaceuticals and Orexigen Therapeutics. She is an advisor to the Mellon Group, a member of the Longitude Capital Industry Advisory Board and is the principal of Great Meadow Consultancy. She was a Senior Advisor to The Monitor Group, now Deloitte, from 2010 to 2012. She also serves on the board of Special Equestrians, a non-profit.

Basic Compensation

Total Annual Compensation, USD 89,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 373,051
Fiscal Year Total, USD 462,051

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

9,380,490

James Frates

2,828,540

Elliot Ehrich

3,547,020

Iain Brown

--

David Gaffin

--

Michael Landine

--
As Of  31 Dec 2017